Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 24
1991 73
1992 138
1993 227
1994 225
1995 311
1996 337
1997 348
1998 375
1999 383
2000 404
2001 437
2002 507
2003 460
2004 427
2005 436
2006 399
2007 372
2008 370
2009 383
2010 394
2011 444
2012 435
2013 429
2014 418
2015 410
2016 315
2017 310
2018 319
2019 333
2020 313
2021 281
Text availability
Article attribute
Article type
Publication date

Search Results

10,204 results
Results by year
Filters applied: . Clear all
Page 1
Clinical pharmacokinetics of losartan.
Sica DA, Gehr TW, Ghosh S. Sica DA, et al. Clin Pharmacokinet. 2005;44(8):797-814. doi: 10.2165/00003088-200544080-00003. Clin Pharmacokinet. 2005. PMID: 16029066 Review.
Losartan is the first orally available angiotensin-receptor antagonist without agonist properties. ...Losartan, or its E 3174 metabolite, is not removed during haemodialysis. ...
Losartan is the first orally available angiotensin-receptor antagonist without agonist properties. ...Losartan, or its E 3174
Losartan: Comprehensive Profile.
Al-Majed AR, Assiri E, Khalil NY, Abdel-Aziz HA. Al-Majed AR, et al. Profiles Drug Subst Excip Relat Methodol. 2015;40:159-94. doi: 10.1016/bs.podrm.2015.02.003. Epub 2015 Apr 9. Profiles Drug Subst Excip Relat Methodol. 2015. PMID: 26051686 Review.
Losartan (Cozaar) is an angiotensin II receptor antagonist with antihypertensive activity. ...Physical characteristics including: ionization constant, solubility, X-ray powder diffraction pattern, thermal methods of analysis, UV spectrum, IR spectrum, mass spectrum with fr
Losartan (Cozaar) is an angiotensin II receptor antagonist with antihypertensive activity. ...Physical characteristics including: ion
[Losartan].
Quetglas EG, Sádaba B, Escolar M, Honorato J. Quetglas EG, et al. Rev Med Univ Navarra. 1997 Jul-Sep;41(3):193-7. Rev Med Univ Navarra. 1997. PMID: 10420926 Review. Spanish. No abstract available.
Pharmacokinetic evaluation of losartan.
Burnier M, Wuerzner G. Burnier M, et al. Expert Opin Drug Metab Toxicol. 2011 May;7(5):643-9. doi: 10.1517/17425255.2011.570333. Epub 2011 Mar 22. Expert Opin Drug Metab Toxicol. 2011. PMID: 21417956 Review.
As the first angiotensin II receptor blocker (ARB) on the market, losartan belongs to the most frequently prescribed ARB. AREA COVERED: The present review examines the pharmacokinetics of losartan with a special discussion on the dose of losartan that should …
As the first angiotensin II receptor blocker (ARB) on the market, losartan belongs to the most frequently prescribed ARB. AREA COVERE …
Losartan in diabetic nephropathy.
Perico N, Ruggenenti P, Remuzzi G. Perico N, et al. Expert Rev Cardiovasc Ther. 2004 Jul;2(4):473-83. doi: 10.1586/14779072.2.4.473. Expert Rev Cardiovasc Ther. 2004. PMID: 15225108 Review.
Losartan also lowered albumin excretion rate in microalbuminuric patients with Type 2 diabetes mellitus. Moreover, the large multicenter Reduction of End points in Noninsulin dependent diabetes mellitus with the Angiotensin II Antagonist Losartan (RENAAL) trial has
Losartan also lowered albumin excretion rate in microalbuminuric patients with Type 2 diabetes mellitus. Moreover, the large multicen
Discussion.
[No authors listed] [No authors listed] J Thorac Cardiovasc Surg. 2014 Dec;148(6):2557-8. doi: 10.1016/j.jtcvs.2014.07.057. Epub 2014 Aug 27. J Thorac Cardiovasc Surg. 2014. PMID: 25172321 Free article. No abstract available.
Losartan: a review of its use, with special focus on elderly patients.
Simpson KL, McClellan KJ. Simpson KL, et al. Drugs Aging. 2000 Mar;16(3):227-50. doi: 10.2165/00002512-200016030-00006. Drugs Aging. 2000. PMID: 10803861 Review.
In patients with heart failure the renal tolerability of losartan was similar to that of captopril, but losartan was associated with a lower withdrawal rate because of adverse events. ...Morbidity and mortality data from the Losartan Heart Failure Survival (E …
In patients with heart failure the renal tolerability of losartan was similar to that of captopril, but losartan was associate …
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
Kjeldsen SE, Lyle PA, Kizer JR, Oparil S, Høieggen A, Os I. Kjeldsen SE, et al. Vasc Health Risk Manag. 2007;3(3):299-305. Vasc Health Risk Manag. 2007. PMID: 17703637 Free PMC article. Review.
The renin-angiotensin-aldosterone-system-activating effect of hydrochlorothiazide augments the efficacy of blocking the angiotensin II type 1 (AT1) receptor with losartan. Some adverse effects associated with hydrochlorothiazide, including increased risk for new-onset diab …
The renin-angiotensin-aldosterone-system-activating effect of hydrochlorothiazide augments the efficacy of blocking the angiotensin II type …
Part 1. Uric acid and losartan.
Sica DA, Schoolwerth AC. Sica DA, et al. Curr Opin Nephrol Hypertens. 2002 Sep;11(5):475-82. doi: 10.1097/00041552-200209000-00001. Curr Opin Nephrol Hypertens. 2002. PMID: 12187310 Review.
PURPOSE OF REVIEW: To characterize the mechanism and clinical impact of the angiotensin-receptor blocker losartan on both renal uric acid handling and thereby serum uric acid. ...This probenecid-like effect of losartan occurs shortly after drug administration, and i …
PURPOSE OF REVIEW: To characterize the mechanism and clinical impact of the angiotensin-receptor blocker losartan on both renal uric …
Losartan as an alternative to ACE inhibitors in patients with renal dysfunction.
Esmail ZN, Loewen PS. Esmail ZN, et al. Ann Pharmacother. 1998 Oct;32(10):1096-8. doi: 10.1345/aph.18014. Ann Pharmacother. 1998. PMID: 9793603 Review.
Losartan-induced acute renal failure may occur in patients sensitive to reduced renal plasma flow. ...In patients with underlying renal dysfunction, regardless of whether they tolerate ACE inhibitors, losartan may be used if deemed necessary. Renal function should b
Losartan-induced acute renal failure may occur in patients sensitive to reduced renal plasma flow. ...In patients with underlying ren
10,204 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page